Clay B. Siegall - Nov 21, 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
President and CEO, Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Nov 21, 2024
Transactions value $
$962,181
Form type
4
Date filed
11/25/2024, 08:41 AM
Previous filing
Aug 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $630K +66.1K +15.74% $9.54 486K Nov 21, 2024 Direct F1
transaction IMNM Common Stock Purchase $332K +33.9K +6.99% $9.78 520K Nov 22, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction report was $9.5412, and the range of prices were between $9.41 and 9.68. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 The weighted average purchase price for the transaction report was $9.7787, and the range of prices were between $9.41 and $9.90. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.